Price–earnings ratio

Wesfarmers' sale of Coregas for $770 million marks a strategic shift in asset management, impacting its valuation and future growth strategies on the ASX.

2024-12-20T03:19:50+0000

Metcash sees stable supermarket growth, but hardware and liquor struggle, prompting a hold recommendation despite acquisition boosts.

2024-12-11T05:34:31+0000

Integral Diagnostics strengthens its market position by acquiring Capital Health, approved by ASIC. The merger presents significant investment opportunities due to undervaluation.

2024-12-11T04:42:45+0000

Discover why Pro Medicus (ASX: PME) is captivating investors with a record-breaking $330 million contract, strong momentum, and analyst upgrades despite valuation concerns.

2024-12-05T03:10:47+0000

This year is thought to be a turnaround year for the Hang Seng Index, but doubts on the recovery prospects for Hong Kong's markets have resurfaced lately.

2024-11-20T04:57:25+0000

TechnologyOne achieves a 15% profit increase, driven by strong UK sales and Software as a Service growth. With their ambitious revenue goals, the company presents a compelling case for long-term investors.

2024-11-19T04:01:24+0000

Aristocrat Leisure’s net profit rose 17%, backed by strong North American results and strategic moves. With a growing dividend, Aristocrat presents an attractive investment outlook.

2024-11-13T05:04:55+0000

Endeavour Group reported modest growth in hotel sales for Q1 2025, while retail liquor sales stayed flat, reflecting changing consumer trends impacting profitability.

2024-11-11T04:26:11+0000